Jan 9, 2025, 16:35
Ahmed Kotb: Ph-like ALL Signaling Pathways and Targets
Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company, shared a post on X:
“Ph-like ALL Signaling Pathways and Targets.
JAK-STAT Signaling:
- Altered by CRLF2, JAK2, EPOR
- Targets: JAK inhibitors, PI3K/mTOR inhibitors
ABL Signaling:
- Fusion proteins (ABL1/2, PDGFRA/B)
- Targets: Kinase inhibitors (dasatinib)
Other Signaling:
- Rare fusion(NTRK3, FLT3.”
More posts featuring Ahmed Kotb.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 9, 2025, 16:35
Jan 9, 2025, 16:32
Jan 9, 2025, 16:20
Jan 9, 2025, 16:07
Jan 9, 2025, 16:04
Jan 9, 2025, 16:02